Format
Sort by
Items per page

Send to

Choose Destination

Best matches for O’Connor CM[au]:

Search results

Items: 1 to 50 of 883

1.

Design of a "Lean" Case Report Form for Heart Failure Device Development.

Psotka MA, Fiuzat M, Carson PE, Kao DP, Cerkvenik J, Schaber DE, Verta P, Kazmierski RT, Shinnar M, Stockbridge N, Unger EF, Zuckerman B, Butler J, Felker GM, Konstam MA, Lindenfeld J, Solomon SD, Teerlink JR, O'Connor CM, Abraham WT.

JACC Heart Fail. 2019 Aug 2. pii: S2213-1779(19)30542-6. doi: 10.1016/j.jchf.2019.07.001. [Epub ahead of print] Review.

2.

Why Should We Publish All Clinical Trials?

O'Connor CM.

JACC Heart Fail. 2019 Aug;7(8):730. doi: 10.1016/j.jchf.2019.06.009. No abstract available.

PMID:
31370967
3.

Reply: Standardized and Tailored Approach to Therapies for Cardiogenic Shock.

Tehrani BN, O'Connor CM.

J Am Coll Cardiol. 2019 Jul 30;74(4):593-594. doi: 10.1016/j.jacc.2019.05.039. No abstract available.

PMID:
31345439
4.

Trajectories of Changes in Renal Function in Patients with Acute Heart Failure.

Beldhuis IE, Streng KW, van der Meer P, Maaten JMT, O'Connor CM, Metra M, Dittrich HC, Ponikowski P, Cotter G, Cleland JGF, Davison BA, Givertz MM, Teerlink JR, Bloomfield DM, Voors AA, Damman K.

J Card Fail. 2019 Jul 15. pii: S1071-9164(19)30070-3. doi: 10.1016/j.cardfail.2019.07.004. [Epub ahead of print]

5.

N-of-1 Clinical Trials.

O'Connor CM.

JACC Heart Fail. 2019 Jul;7(7):630-631. doi: 10.1016/j.jchf.2019.05.004. No abstract available.

PMID:
31248572
6.

Impact of baseline covariate imbalance on bias in treatment effect estimation in cluster randomized trials: Race as an example.

Yang S, Starks MA, Hernandez AF, Turner EL, Califf RM, O'Connor CM, Mentz RJ, Choudhury KR.

Contemp Clin Trials. 2019 Jun 19. pii: S1551-7144(18)30730-4. doi: 10.1016/j.cct.2019.04.016. [Epub ahead of print]

PMID:
31228563
7.

Erratum to 'The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions' [Eur J Heart Fail 2018;20:963-972].

Ambrosy AP, Mentz RJ, Fiuzat M, Cleland JGF, Greene SJ, O'Connor CM, Teerlink JR, Zannad F, Solomon SD.

Eur J Heart Fail. 2019 Jun;21(6):819. doi: 10.1002/ejhf.1480. Epub 2019 May 9. No abstract available.

PMID:
31222927
8.

Novel approaches to the management of chronic systolic heart failure: future directions and unanswered questions.

Reddy YNV, Borlaug BA, O'Connor CM, Gersh BJ.

Eur Heart J. 2019 Jun 14. pii: ehz364. doi: 10.1093/eurheartj/ehz364. [Epub ahead of print]

PMID:
31199474
9.

Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure.

Felker GM, Borentain M, Cleland JG, DeSouza MM, Kessler PD, O'Connor CM, Seiffert D, Teerlink JR, Voors AA, McMurray JJV.

Eur J Heart Fail. 2019 Aug;21(8):1022-1031. doi: 10.1002/ejhf.1504. Epub 2019 Jun 6.

PMID:
31168885
10.

African Americans With Advanced Heart Failure Are More Likely to Die in a Health Care Facility Than at Home or in Hospice: An Analysis From the PAL-HF Trial.

Warraich HJ, O'Connor CM, Yang H, Granger BB, Johnson KS, Mark DB, Anstrom KJ, Patel CB, Steinhauser KE, Tulsky JA, Taylor DH Jr, Rogers JG, Mentz RJ.

J Card Fail. 2019 Aug;25(8):693-694. doi: 10.1016/j.cardfail.2019.05.013. Epub 2019 May 31. No abstract available.

PMID:
31158470
11.

Correction: Two purified domains of telomerase reverse transcriptase reconstitute sequence-specific interactions with RNA.

O'Connor CM, Lai CK, Collins K.

J Biol Chem. 2019 May 31;294(22):8713. doi: 10.1074/jbc.AAC119.009170. No abstract available.

12.

Better Quality of Life Over More Quantity of Life: How We View Time Trade-Off.

O'Connor CM.

JACC Heart Fail. 2019 Jun;7(6):531-532. doi: 10.1016/j.jchf.2019.05.001. No abstract available.

PMID:
31146877
13.

The Highly Recurrent PP2A Aα-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis.

Taylor SE, O'Connor CM, Wang Z, Shen G, Song H, Leonard D, Sangodkar J, LaVasseur C, Avril S, Waggoner S, Zanotti K, Armstrong AJ, Nagel C, Resnick K, Singh S, Jackson MW, Xu W, Haider S, DiFeo A, Narla G.

Cancer Res. 2019 Aug 15;79(16):4242-4257. doi: 10.1158/0008-5472.CAN-19-0218. Epub 2019 May 29.

PMID:
31142515
14.

Rationale and Design of the VITALITY-HFpEF Trial.

Butler J, Lam CSP, Anstrom KJ, Ezekowitz J, Hernandez AF, O'Connor CM, Pieske B, Ponikowski P, Shah SJ, Solomon SD, Voors AA, Wu Y, Carvalho F, Bamber L, Blaustein RO, Roessig L, Armstrong PW.

Circ Heart Fail. 2019 May;12(5):e005998. doi: 10.1161/CIRCHEARTFAILURE.119.005998.

PMID:
31096775
15.

Guideline-Directed Medical Therapy Clinics: A Call to Action for the Heart Failure Team.

O'Connor CM.

JACC Heart Fail. 2019 May;7(5):442-443. doi: 10.1016/j.jchf.2019.04.001. No abstract available.

PMID:
31047024
16.

Heart Failure Site-Based Research in the United States: Results of the Heart Failure Society of America Research Network Survey.

Psotka MA, Ammon SE, Fiuzat M, Bozkurt B, Chung ES, Cole RT, Greene SJ, Kraus D, Ky B, McIlvennan CK, Shah P, Teerlink JR, Walsh MN, Jessup M, O'Connor CM.

JACC Heart Fail. 2019 May;7(5):431-438. doi: 10.1016/j.jchf.2019.02.008. Epub 2019 Apr 10.

PMID:
30981742
17.

Standardized Team-Based Care for Cardiogenic Shock.

Tehrani BN, Truesdell AG, Sherwood MW, Desai S, Tran HA, Epps KC, Singh R, Psotka M, Shah P, Cooper LB, Rosner C, Raja A, Barnett SD, Saulino P, deFilippi CR, Gurbel PA, Murphy CE, O'Connor CM.

J Am Coll Cardiol. 2019 Apr 9;73(13):1659-1669. doi: 10.1016/j.jacc.2018.12.084. Erratum in: J Am Coll Cardiol. 2019 Jul 23;74(3):481.

18.

Heart Failure Fake News: How Do We Distinguish the Truth?

O'Connor CM.

JACC Heart Fail. 2019 Apr;7(4):363. doi: 10.1016/j.jchf.2019.02.004. No abstract available.

PMID:
30922511
19.

Heart Failure in Women.

Lindenfeld J, O'Connor CM.

JACC Heart Fail. 2019 Mar;7(3):274-275. doi: 10.1016/j.jchf.2019.01.012. No abstract available.

PMID:
30819385
20.

Do Women and Men Respond Similarly to Therapies in Contemporary Heart Failure Clinical Trials?

Vaduganathan M, Tahhan AS, Alrohaibani A, Greene SJ, Fonarow GC, Vardeny O, Lindenfeld J, Jessup M, Fiuzat M, O'Connor CM, Butler J.

JACC Heart Fail. 2019 Mar;7(3):267-271. doi: 10.1016/j.jchf.2018.12.016. Review. No abstract available.

PMID:
30819383
21.

Protein phosphatase 2A Aα regulates Aβ protein expression and stability.

O'Connor CM, Hoffa MT, Taylor SE, Avelar RA, Narla G.

J Biol Chem. 2019 Apr 12;294(15):5923-5934. doi: 10.1074/jbc.RA119.007593. Epub 2019 Feb 22.

PMID:
30796164
22.

Author Correction: Direct benefits and evolutionary transitions to complex societies.

Dey CJ, O'Connor CM, Wilkinson H, Shultz S, Balshine S, Fitzpatrick JL.

Nat Ecol Evol. 2019 Mar;3(3):500. doi: 10.1038/s41559-019-0830-5.

PMID:
30760916
23.

Recognizing Heart Failure Awareness Week.

O'Connor CM.

JACC Heart Fail. 2019 Feb;7(2):173. doi: 10.1016/j.jchf.2018.12.013. No abstract available.

PMID:
30704606
24.

Human cytomegalovirus G protein-coupled receptor US28 promotes latency by attenuating c-fos.

Krishna BA, Humby MS, Miller WE, O'Connor CM.

Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1755-1764. doi: 10.1073/pnas.1816933116. Epub 2019 Jan 15.

25.

NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF.

Daubert MA, Adams K, Yow E, Barnhart HX, Douglas PS, Rimmer S, Norris C, Cooper L, Leifer E, Desvigne-Nickens P, Anstrom K, Fiuzat M, Ezekowitz J, Mark DB, O'Connor CM, Januzzi J, Felker GM.

JACC Heart Fail. 2019 Feb;7(2):158-168. doi: 10.1016/j.jchf.2018.10.014. Epub 2019 Jan 2.

PMID:
30611722
26.

JACC: Heart Failure Peer Review Hall of Fame 2018.

O'Connor CM.

JACC Heart Fail. 2019 Jan;7(1):81. doi: 10.1016/j.jchf.2018.12.001. No abstract available.

PMID:
30606487
27.

Aviation Emergencies for Heart Failure Cardiologists: A New Twist to the Heart Team.

O'Connor CM.

JACC Heart Fail. 2018 Dec;6(12):1047-1048. doi: 10.1016/j.jchf.2018.10.018. No abstract available.

PMID:
30497645
28.

Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure.

Mark DB, Cowper PA, Anstrom KJ, Sheng S, Daniels MR, Knight JD, Baloch KN, Davidson-Ray L, Fiuzat M, Januzzi JL Jr, Whellan DJ, Piña IL, Ezekowitz JA, Adams KF, Cooper LS, O'Connor CM, Felker GM.

J Am Coll Cardiol. 2018 Nov 27;72(21):2551-2562. doi: 10.1016/j.jacc.2018.08.2184.

PMID:
30466512
29.

The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts.

Nukui M, O'Connor CM, Murphy EA.

Viruses. 2018 Nov 7;10(11). pii: E614. doi: 10.3390/v10110614.

30.

COAPTing Heart Failure Physicians, Interventional Cardiologists, and CardioThoracic Surgeons: A New Opportunity for Patients.

O'Connor CM.

JACC Heart Fail. 2018 Nov;6(11):967-968. doi: 10.1016/j.jchf.2018.09.007. No abstract available.

PMID:
30384916
31.

Bridging the gap: From reablement policy to practice for people with dementia.

Poulos RG, Gresham M, O'Connor CM, Poulos CJ.

Alzheimers Dement (N Y). 2018 Oct 4;4:508-509. doi: 10.1016/j.trci.2018.08.008. eCollection 2018. No abstract available.

32.

Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points.

Greene SJ, Hernandez AF, Sun JL, Butler J, Armstrong PW, Ezekowitz JA, Zannad F, Ferreira JP, Coles A, Metra M, Voors AA, Califf RM, O'Connor CM, Mentz RJ.

Circ Cardiovasc Qual Outcomes. 2018 Oct;11(10):e004783. doi: 10.1161/CIRCOUTCOMES.118.004783.

PMID:
30354576
33.

Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure.

Greene SJ, Mentz RJ, Fiuzat M, Butler J, Solomon SD, Ambrosy AP, Mehta C, Teerlink JR, Zannad F, O'Connor CM.

Circulation. 2018 Sep 4;138(10):1039-1053. doi: 10.1161/CIRCULATIONAHA.118.034668.

PMID:
30354535
34.

Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes.

Parikh KS, Fiuzat M, Davis G, Neely M, Blain-Nelson P, Whellan DJ, Abraham WT, Adams KF Jr, Felker GM, Liggett SB, O'Connor CM, Bristow MR.

Circ Genom Precis Med. 2018 Aug;11(8):e002210. doi: 10.1161/CIRCGEN.117.002210.

35.

Bovine tuberculosis in working foxhounds: lessons learned from a complex public health investigation.

Phipps E, McPhedran K, Edwards D, Russell K, O'Connor CM, Gunn-Moore DA, O'Halloran C, Roberts T, Morris J.

Epidemiol Infect. 2018 Oct 9:1-6. doi: 10.1017/S0950268818002753. [Epub ahead of print]

36.

Renal Function and Exercise Training in AmbulatoryHeart Failure Patients With a Reduced Ejection Fraction.

Ambrosy AP, Mulder H, Coles A, Krauss WE, Lam CSP, McCullough PA, Pina I, Tromp J, Whellan DJ, O'Connor CM, Mentz RJ.

Am J Cardiol. 2018 Sep 15;122(6):999-1007. doi: 10.1016/j.amjcard.2018.06.011. Epub 2018 Jun 23.

PMID:
30269900
37.

Depression in Heart Failure: Beyond a SADHART.

O'Connor CM.

JACC Heart Fail. 2018 Oct;6(10):885-886. doi: 10.1016/j.jchf.2018.08.004. No abstract available.

PMID:
30262113
38.

Mycobacterium bovis tuberculosis in hunting hounds.

Phipps E, McPhedran K, Edwards D, Russell K, O'Connor CM, Morris J, O'Halloran C, Gunn-Moore D.

Vet Rec. 2018 Sep 22;183(11):356. doi: 10.1136/vr.k3962. No abstract available.

PMID:
30237193
39.
40.

Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF).

Fudim M, Parikh KS, Dunning A, DeVore AD, Mentz RJ, Schulte PJ, Armstrong PW, Ezekowitz JA, Tang WHW, McMurray JJV, Voors AA, Drazner MH, O'Connor CM, Hernandez AF, Patel CB.

Am J Cardiol. 2018 Nov 1;122(9):1506-1512. doi: 10.1016/j.amjcard.2018.07.023. Epub 2018 Aug 3.

PMID:
30172362
41.

Relationship between changing patient-reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF-ACTION.

Luo N, O'Connor CM, Cooper LB, Sun JL, Coles A, Reed SD, Whellan DJ, Piña IL, Kraus WE, Mentz RJ.

Eur J Heart Fail. 2019 Jan;21(1):63-70. doi: 10.1002/ejhf.1299. Epub 2018 Aug 31.

PMID:
30168635
42.

Politically Correct Heart Failure Research in America to Avoid Geographic Variation.

O'Connor CM.

JACC Heart Fail. 2018 Sep;6(9):805-806. doi: 10.1016/j.jchf.2018.07.010. No abstract available.

PMID:
30166027
43.

Loop diuretic adjustments in patients with chronic heart failure: Insights from HF-ACTION.

Fudim M, O'Connor CM, Mulder H, Coles A, Bhatt AS, Ambrosy AP, Kraus WE, Piña IL, Whellan DJ, Mentz RJ.

Am Heart J. 2018 Nov;205:133-141. doi: 10.1016/j.ahj.2018.06.017. Epub 2018 Jul 29.

PMID:
30158057
44.

Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials: A Systematic Review.

Tahhan AS, Vaduganathan M, Greene SJ, Fonarow GC, Fiuzat M, Jessup M, Lindenfeld J, O'Connor CM, Butler J.

JAMA Cardiol. 2018 Oct 1;3(10):1011-1019. doi: 10.1001/jamacardio.2018.2559.

PMID:
30140928
45.

US28: HCMV's Swiss Army Knife.

Krishna BA, Miller WE, O'Connor CM.

Viruses. 2018 Aug 20;10(8). pii: E445. doi: 10.3390/v10080445. Review.

46.

Worsening renal function during decongestion among patients hospitalized for heart failure: Findings from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial.

Fudim M, Loungani R, Doerfler SM, Coles A, Greene SJ, Cooper LB, Fiuzat M, O'Connor CM, Rogers JG, Mentz RJ.

Am Heart J. 2018 Oct;204:163-173. doi: 10.1016/j.ahj.2018.07.019. Epub 2018 Jul 29.

PMID:
30121018
47.

Palliative care and hospital readmissions in patients with advanced heart failure: Insights from the PAL-HF trial.

Mentz RJ, O'Connor CM, Granger BB, Yang H, Patel CB, Steinhauser KE, Fiuzat M, Johnson KS, Anstrom KJ, Dodson GC, Taylor DH Jr, Mark DB, Tulsky JA, Rogers JG.

Am Heart J. 2018 Oct;204:202-204. doi: 10.1016/j.ahj.2018.07.010. Epub 2018 Jul 20. No abstract available.

PMID:
30100051
48.

Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.

Jiang W, Whellan DJ, Adams KF, Babyak MA, Boyle SH, Wilson JL, Patel CB, Rogers JG, Harris WS, O'Connor CM.

JACC Heart Fail. 2018 Oct;6(10):833-843. doi: 10.1016/j.jchf.2018.03.011. Epub 2018 Aug 8.

PMID:
30098961
49.

Selective 4-Thiouracil Labeling of RNA Transcripts within Latently Infected Cells after Infection with Human Cytomegalovirus Expressing Functional Uracil Phosphoribosyltransferase.

Roche KL, Nukui M, Krishna BA, O'Connor CM, Murphy EA.

J Virol. 2018 Oct 12;92(21). pii: e00880-18. doi: 10.1128/JVI.00880-18. Print 2018 Nov 1.

50.

HFpEF: From Early Observations to Worldwide Awareness.

O'Connor CM.

JACC Heart Fail. 2018 Aug;6(8):718-719. doi: 10.1016/j.jchf.2018.07.001. No abstract available.

Supplemental Content

Loading ...
Support Center